Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cadiot

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Gastroenterology|March 1, 1996
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesR Modigliani, J F Colombel, J L Dupas, et al.
Neuroendocrinology|August 23, 2008
Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in FranceC Lombard-Bohas, E Mitry, D O'Toole, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.
European Journal of Endocrinology|May 10, 2011
Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs EndocrinesP Goudet, C Bonithon-Kopp, A Murat, et al.
Gut|December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 17, 2015
MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs EndocrinesP Goudet, A Dalac, M Le Bras, et al.
Journal of Crohn'S & Colitis|December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAIDA Buisson, J Filippi, A Amiot, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2014
Olmesartan-associated enteropathy: results of a national surveyL Marthey, G Cadiot, P Seksik, et al.
Gastroenterologie Clinique Et Biologique|July 23, 1999
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]J C Barbare, L Bedenne, O Bouché, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Gastroenterology|March 1, 1996
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesR Modigliani, J F Colombel, J L Dupas, et al.
Neuroendocrinology|August 23, 2008
Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in FranceC Lombard-Bohas, E Mitry, D O'Toole, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.
European Journal of Endocrinology|May 10, 2011
Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs EndocrinesP Goudet, C Bonithon-Kopp, A Murat, et al.
Gut|December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 17, 2015
MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs EndocrinesP Goudet, A Dalac, M Le Bras, et al.
Journal of Crohn'S & Colitis|December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAIDA Buisson, J Filippi, A Amiot, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2014
Olmesartan-associated enteropathy: results of a national surveyL Marthey, G Cadiot, P Seksik, et al.
Gastroenterologie Clinique Et Biologique|July 23, 1999
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]J C Barbare, L Bedenne, O Bouché, et al.
Pageof 12